Opiant Pharmaceuticals Announces Second Quarter 2020 Financial Results and Corporate Update

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three months ended June 30,